Revista da Sociedade Portuguesa de Dermatologia e Venereologia (Jan 2023)
Erythema multiforme caused by topical imiquimod 3.75%
Abstract
Imiquimod, 3.75% cream, is a topical immunomodulator approved for treating actinic keratoses. Although local side effects are more frequent, it can also have systemic side effects. We report that imiquimod 3.75% can also produce erythema multiforme (EM), thus discarding it as an alternative to imiquimod 5% on this adverse effect.